Literature DB >> 20307513

Bone marrow stromal cell transplantation for treatment of sub-acute spinal cord injury in the rat.

Chizuka Ide1, Yoshiyasu Nakai, Norihiko Nakano, Tae-Beom Seo, Yoshihiro Yamada, Katsuaki Endo, Toru Noda, Fukuki Saito, Yoshihisa Suzuki, Masanori Fukushima, Toshio Nakatani.   

Abstract

Bone marrow stromal cells (BMSCs) have been studied as effective transplants for the treatment of spinal cord injury (SCI). Our previous study showed that BMSCs infused into the cerebrospinal fluid (CSF) exhibited distinct effects on the recovery of acute SCI. The present study examined the effects of BMSCs in sub-acute SCI (2weeks post-injury) by transplanting them directly into the lesion. The spinal cord was crush-injured at the Th8-9 level in rats, and 2weeks later, cultured BMSCs (5x10(5)) derived from GFP-transgenic rats of the same strain were transplanted into the lesion. Tissue repair and nerve regeneration were examined by immunohistochemistry and electron microscopy. GFP-labeled BMSCs survived as cell assemblies in the spinal cord for 1-2weeks after transplantation. The dorsal side of BMSC assemblies in the spinal cord usually showed an expanded GFAP-negative, astrocyte-devoid area, in which extracellular matrices including collagen fibrils were deposited. Numerous regenerating axons associated with Schwann cells grew out through such astrocyte-devoid extracellular matrices. Ascending (CGRP-containing) and descending (5HT- and TH-containing) axons were included in these regenerating axons. Regenerated axons were myelinated by Schwann cells beyond 2weeks post-transplantation. Cavity formation was reduced in the cell transplantation group. Locomotory behavior assessed by the BBB scale improved to 9.8 points in the cell transplantation group, while it was to 5.5-5.7 in the control. BMSC transplantation into lesions of advanced SCI has markedly beneficial effects on tissue repair and axonal outgrowth, leading to improved locomotion in rats. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20307513     DOI: 10.1016/j.brainres.2010.03.043

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  41 in total

1.  Neuroprotective effect of bone marrow stromal cell combination with atorvastatin in rat model of spinal cord injury.

Authors:  Fang Li; Dan Fei; Libo Sun; Sixun Zhang; Yue Yuan; Li Zhang; Kuiming Zhao; Rui Li; Yanbing Yu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  PET molecular imaging in stem cell therapy for neurological diseases.

Authors:  Jiachuan Wang; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-23       Impact factor: 9.236

3.  A defined mix of cytokines mimics conditioned medium from cultures of bone marrow-derived mesenchymal stem cells and elicits bone regeneration.

Authors:  Wataru Katagiri; Kohei Sakaguchi; Takamasa Kawai; Yukiko Wakayama; Masashi Osugi; Hideharu Hibi
Journal:  Cell Prolif       Date:  2017-01-30       Impact factor: 6.831

4.  Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects.

Authors:  Masashi Osugi; Wataru Katagiri; Ryoko Yoshimi; Takeharu Inukai; Hideharu Hibi; Minoru Ueda
Journal:  Tissue Eng Part A       Date:  2012-06-12       Impact factor: 3.845

5.  Locomotor improvement of spinal cord-injured rats through treadmill training by forced plantar placement of hind paws.

Authors:  M Hayashibe; T Homma; K Fujimoto; T Oi; N Yagi; M Kashihara; N Nishikawa; Y Ishizumi; S Abe; H Hashimoto; K Kanekiyo; H Imagita; C Ide; S Morioka
Journal:  Spinal Cord       Date:  2015-10-20       Impact factor: 2.772

6.  Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury.

Authors:  Hideaki Nakajima; Kenzo Uchida; Alexander Rodriguez Guerrero; Shuji Watanabe; Daisuke Sugita; Naoto Takeura; Ai Yoshida; Guang Long; Karina T Wright; William E B Johnson; Hisatoshi Baba
Journal:  J Neurotrauma       Date:  2012-04-18       Impact factor: 5.269

Review 7.  Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?

Authors:  Fábio G Teixeira; Miguel M Carvalho; Nuno Sousa; António J Salgado
Journal:  Cell Mol Life Sci       Date:  2013-03-01       Impact factor: 9.261

8.  Peripheral Nerve Regeneration by Secretomes of Stem Cells from Human Exfoliated Deciduous Teeth.

Authors:  Yukiko Sugimura-Wakayama; Wataru Katagiri; Masashi Osugi; Takamasa Kawai; Kenichi Ogata; Kohei Sakaguchi; Hideharu Hibi
Journal:  Stem Cells Dev       Date:  2015-08-10       Impact factor: 3.272

9.  Spinal cord injury in rats treated using bone marrow mesenchymal stem-cell transplantation.

Authors:  Yu-Bing Chen; Quan-Zhang Jia; Dong-Jun Li; Jing-Hai Sun; Shuang Xi; Li-Ping Liu; De-Xuan Gao; Da-Wei Jiang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

10.  Effects of bone marrow stromal cell transplantation through CSF on the subacute and chronic spinal cord injury in rats.

Authors:  Norihiko Nakano; Yoshiyasu Nakai; Tae-Beom Seo; Tamami Homma; Yoshihiro Yamada; Masayoshi Ohta; Yoshihisa Suzuki; Toshio Nakatani; Masanori Fukushima; Miki Hayashibe; Chizuka Ide
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.